RUBIUS THERAPEUTICS INC's ticker is RUBY and the CUSIP is 78116T103. A total of 42 filers reported holding RUBIUS THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $10,000 | -82.1% | 23,784 | -64.0% | 0.00% | – |
| Q2 2022 | $56,000 | -73.1% | 66,129 | +75.1% | 0.00% | – |
| Q1 2022 | $208,000 | -22.4% | 37,765 | +151.8% | 0.00% | – |
| Q3 2021 | $268,000 | -78.2% | 15,000 | -70.2% | 0.00% | – |
| Q2 2021 | $1,228,000 | -65.7% | 50,300 | -62.7% | 0.00% | -100.0% |
| Q1 2021 | $3,578,000 | +4210.8% | 135,028 | +1130.1% | 0.00% | – |
| Q4 2020 | $83,000 | -46.1% | 10,977 | -64.2% | 0.00% | – |
| Q3 2020 | $154,000 | – | 30,642 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ARCH Venture Management, LLC | 2,618,351 | $11,652,000 | 19.67% |
| Flagship Pioneering Inc. | 38,296,526 | $170,419,000 | 7.99% |
| HARBOURVEST PARTNERS LLC | 986,878 | $4,392,000 | 2.12% |
| Abbot Financial Management, Inc. | 563,500 | $2,508,000 | 2.04% |
| Artal Group S.A. | 3,883,791 | $17,283,000 | 0.73% |
| ARK Investment Management | 318,121 | $1,416,000 | 0.04% |
| Walleye Capital LLC | 34,000 | $151,000 | 0.03% |
| Tekla Capital Management LLC | 155,982 | $694,000 | 0.03% |
| Baillie Gifford | 4,256,900 | $18,943,000 | 0.02% |
| FEDERATED HERMES, INC. | 600,000 | $2,670,000 | 0.01% |